PDS Biotechnology (PDSB) Invested Capital (2014 - 2026)
PDS Biotechnology's (PDSB) quarterly Invested Capital came in at $61853.0 in Q4 2025, down 49.7% YoY from $122972.0 in Q4 2024, and down 98.97% on a QoQ basis from $6.0 million in Q3 2025.
PDS Biotechnology (PDSB) Invested Capital (2014 - 2026) Analysis & Trends
PDS Biotechnology (PDSB) has 8 years of Invested Capital data on file, last reported at $61853.0 in Q4 2025.
- Quarterly Invested Capital fell 49.7% year-over-year to $61853.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 million (up 985.15% YoY) and the FY2025 annual result came in at $61853.0, down 49.7% from the prior year.
- Invested Capital declined to $61853.0 in Q4 2025, from $6.0 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $6.0 million in Q3 2025 to a low of $61853.0 in Q4 2025.
- A 3-year average of $674169.4 and a median of $151505.0 in 2024 frame the typical range for Invested Capital.
- The widest YoY moves for Invested Capital: up 4266.78% in 2025, down 49.7% in 2025.
- Tracing PDSB's Invested Capital over 3 years: stood at $178767.0 in 2023, then tumbled by 31.21% to $122972.0 in 2024, then plunged by 49.7% to $61853.0 in 2025.
- The last three Invested Capital figures came in at $61853.0 (Q4 2025), $6.0 million (Q3 2025), and $93110.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - | 4.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Mn |
| Dec 31, 2025 | 61,853.00 |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 93,110.00 |
| Mar 31, 2025 | 108,211.00 |
| Dec 31, 2024 | 122,972.00 |
| Sep 30, 2024 | 137,401.00 |
| Jun 30, 2024 | 151,505.00 |
| Mar 31, 2024 | 165,292.00 |
| Dec 31, 2023 | 178,767.00 |
| Sep 30, 2023 | 191,938.00 |
| Jun 30, 2023 | 204,814.00 |
| Mar 31, 2018 | 20.90 Mn |
| Dec 31, 2017 | 3.08 Mn |
| Sep 30, 2017 | 5.45 Mn |
| Jun 30, 2017 | 3.09 Mn |
| Mar 31, 2017 | 579,554.00 |
| Jun 30, 2016 | 2.39 Mn |
| Mar 31, 2016 | 2.33 Mn |
| Dec 31, 2015 | 2.27 Mn |